Category: Uncategorized

This article discusses the grants awarded to two research teams within Washington University in St. Louis, to advance racial equity in Alzheimer’s disease research. The studies involved are focused on building a diverse registry that benefits participants and finding factors that place Black people at risk of cognitive decline.

The following article by the BBC highlights our recent study using data from our longitudinal cohort and found that driving may serve as an effective and accurate digital biomarker for identifying preclinical AD among older adults.

Dr. Babulal was awarded an R01 (AG067428) from the National Institute on Aging. This 5-year study will investigate how depression, preclinical Alzheimer disease, and antidepressant use affect driving behavior in cognitively normal older adults (≥ 65 years of age). Depression and symptomatic AD independently increase the risk of an automobile crash. Depression is also a factor […]

Dr. Ganesh Babulal was awarded the Best Poster Award from the Alzheimer’s Disease and Related Dementias Interest Group at the 2019 Gerontological Society of America conference in Austin, TX.

Dr. Roe was selected for the Janet E. Rafferty Scientist-Practitioner Award from Southern Illinois University in recognition of her post-doctoral accomplishments, the quality of her dissertation, and excellence as a clinician and researcher who successfully integrates science and practice.

Dr. Ganesh Babulal was elected as the Vice-Chair of the Diversity and Disparities Professional Interest Area (PIA), one of 19 PIAs in the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment. He will serve in this position for 2 years (2019-2021). Diversity and Disparities PIA 

ISTAART Neuropsychiatric Syndromes PIA: Poster Winners It is our great pleasure to announce that in the junior investigator category, that Ganesh Babulal from Washington University School of Medicine and Deniz Buyukgok from Istanbul University Faculty of Medicine are the co-winners of the Neuropsychiatric Syndromes PIA best poster for the 2018 Alzheimer’s Association International Conference. Their […]

Patients in the later stage of preclinical Alzheimer’s disease (AD) are more likely to fail or perform poorly on a test of driving skills, new research suggests.

The St. Louis Post-Dispatch (Doug Moore) interviewed us about our new study, talked with two of our participants currently enrolled in our studies and discuss the growth of the aging population.

A $5.9 million study at Washington University School of Medicine in St. Louis aims to learn more about how driving habits change with age and with the onset of Alzheimer’s disease, a form of dementia that affects one in 10 people over 65, stealing the ability to think, remember and, consequently, drive. The study led […]

For his research in preclinical AD and driving, Dr. Babulal received the The Alene and Meyer Kopolow Award for Geriatrics, Psychiatry, and Neurology.

Fellowship aims to promote diversity. Project to focus on Racial Differences in Alzheimer’s Disease Biomarkers and Driving Behavior.

Ganesh Babulal, discusses his publication on mood changes and preclinical AD.

Denise Head, associate professor of psychological and brain sciences in Arts & Sciences, discusses how problems on spatial navigation tasks may be an early predictor of Alzheimer’s disease.

[Podcast] Dr. Roe discusses her paper “Noncognitive” symptoms of early Alzheimer disease, published in the journal Neurology.

Research authored by Catherine Roe, PhD, finds that depression and behavioral changes may occur before memory declines in people who will go on to develop Alzheimer’s disease.

[Video] Dr. Roe explains why patients with cancer are less likely to develop Alzheimer’s disease, and patients with Alzheimer’s disease are less likely to get cancer.

Dr. Roe discusses her publication on the relationship between Alzheimer’s disease and cancer.